CLEC19A (C-type lectin domain containing 19A) is a secreted protein member of the C-type lectin family with demonstrated roles in both periodontal and neurological diseases. In glioblastoma multiforme, CLEC19A functions as a putative tumor suppressor: overexpression inhibits glioma cell proliferation and migration while promoting apoptosis through suppression of the PI3K/AKT/NF-κB signaling pathway 1. The protein shows significantly lower expression in glioma tissues compared to healthy brain tissue 1. CLEC19A demonstrates protein binding capability and exhibits tissue-specific expression in brain 1. Genetically, CLEC19A variants associate with multiple periodontitis-related phenotypes including edentulism, pocket depth measurements, and clinical attachment levels in genome-wide association studies 23. These associations suggest involvement in immune response and epithelial barrier function relevant to periodontal disease pathogenesis 3. Additionally, CLEC19A locus variants on chromosome 16 associate with smoking quantity in Finnish populations, with associated SNPs potentially influencing gene expression and linked to the neurotrophin signaling pathway 45. However, this smoking-related association did not replicate in an independent cohort 4, indicating context-dependent genetic effects.